FOXP1 Acts Through a Negative Feedback Loop to Suppress FOXO-induced Apoptosis
Overview
Authors
Affiliations
Transcriptional activity of Forkhead box transcription factor class O (FOXO) proteins can result in a variety of cellular outcomes depending on cell type and activating stimulus. These transcription factors are negatively regulated by the phosphoinositol 3-kinase (PI3K)-protein kinase B (PKB) signaling pathway, which is thought to have a pivotal role in regulating survival of tumor cells in a variety of cancers. Recently, it has become clear that FOXO proteins can promote resistance to anti-cancer therapeutics, designed to inhibit PI3K-PKB activity, by inducing the expression of proteins that provide feedback at different levels of this pathway. We questioned whether such a feedback mechanism may also exist directly at the level of FOXO-induced transcription. To identify critical modulators of FOXO transcriptional output, we performed gene expression analyses after conditional activation of key components of the PI3K-PKB-FOXO signaling pathway and identified FOXP1 as a direct FOXO transcriptional target. Using chromatin immunoprecipitation followed by next-generation sequencing, we show that FOXP1 binds enhancers that are pre-occupied by FOXO3. By sequencing the transcriptomes of cells in which FOXO is specifically activated in the absence of FOXP1, we demonstrate that FOXP1 can modulate the expression of a specific subset of FOXO target genes, including inhibiting expression of the pro-apoptotic gene BIK. FOXO activation in FOXP1-knockdown cells resulted in increased cell death, demonstrating that FOXP1 prevents FOXO-induced apoptosis. We therefore propose that FOXP1 represents an important modulator of FOXO-induced transcription, promoting cellular survival.
Lohmar J, Gross S, Carter-Wientjes C, Mack B, Wei Q, Lebar M PLoS One. 2025; 20(3):e0315766.
PMID: 40029854 PMC: 11875336. DOI: 10.1371/journal.pone.0315766.
Jin X, Chen L, Ji T, Li R World J Gastrointest Oncol. 2024; 16(5):1890-1907.
PMID: 38764814 PMC: 11099439. DOI: 10.4251/wjgo.v16.i5.1890.
Levavasseur F, Oussous S, Zubaidan T, Kosmider O, Pendino F, Rombaut D Blood Adv. 2023; 7(13):3265-3275.
PMID: 36930820 PMC: 10336262. DOI: 10.1182/bloodadvances.2022008585.
Ismailova A, Salehi-Tabar R, Dimitrov V, Memari B, Barbier C, White J Front Immunol. 2023; 14:1123344.
PMID: 36756115 PMC: 9900176. DOI: 10.3389/fimmu.2023.1123344.
Liu M, Yang Q, Han J Arch Virol. 2021; 167(1):131-140.
PMID: 34773511 DOI: 10.1007/s00705-021-05292-8.